| WHO - Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control)

PQT/MED publishes first invitation to manufacturers of Mycobacterium tuberculosis antigen-based skin tests (TBSTs) to submit an Expression of Interest (EOI)

Announcement

17 February, 2025 - 00:12 (CET)

A first invitation to manufacturers of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), to submit an Expression of Interest (EOI) for product evaluation has been published by the WHO Pr

Revised zinc EOI published

10 February, 2025 - 00:12 (CET)

WHO Public Assessment Reports (WHOPARs) published

Announcement

6 February, 2025 - 13:41 (CET)

Active Pharmaceutical Ingredient (API) Prequalified

Announcement

29 January, 2025 - 00:12 (CET)

Albendazole (WHOAPI-427) manufactured by Sequent Scientific Limited has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.